Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) were up 14.3% during trading on Thursday . The company traded as high as $0.24 and last traded at $0.24. Approximately 1,300 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 12,108 shares. The stock had previously closed at $0.21.
Alpha Tau Medical Price Performance
The firm has a fifty day moving average of $0.22 and a 200-day moving average of $0.21.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Further Reading
- Five stocks we like better than Alpha Tau Medical
- What Does Downgrade Mean in Investing?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- What Investors Need to Know to Beat the Market
- Nebius Group: The Rising Star in AI Infrastructure
- Utilities Stocks Explained – How and Why to Invest in Utilities
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
